Elevance Health, Inc. (VIE:ELV)
Austria
· Delayed Price · Currency is EUR | Market Cap | 59.77B |
| Revenue (ttm) | 169.60B |
| Net Income (ttm) | 4.82B |
| Shares Out | n/a |
| EPS (ttm) | 21.47 |
| PE Ratio | 12.39 |
| Forward PE | 12.46 |
| Dividend | 6.00 (2.20%) |
| Ex-Dividend Date | Dec 5, 2025 |
| Volume | n/a |
| Average Volume | 2 |
| Open | 272.80 |
| Previous Close | 276.40 |
| Day's Range | 272.80 - 276.80 |
| 52-Week Range | 237.00 - 413.60 |
| Beta | n/a |
| RSI | 34.85 |
| Earnings Date | Apr 15, 2026 |
About Elevance Health
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, a... [Read more]
Financial Performance
In 2025, Elevance Health's revenue was $199.13 billion, an increase of 12.62% compared to the previous year's $176.81 billion. Earnings were $5.66 billion, a decrease of -5.32%.
Financial numbers in USD Financial StatementsNews
Elevance Health Announces Management Changes; CFO Mark Kaye to Expand Responsibilities to Include Carelon and Felicia Norwood to Lead Consolidated Health Benefits Organization
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) today announced management changes designed to simplify decision-making and strengthen execution across Carelon and Health Benefits. As...
Elevance Health Foundation Commits $2.3 Million to New Food as Medicine Programs Across the Country
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health Foundation has awarded 22 new grants totaling more than $2.3 million to support food as medicine programs across the country. These grants will help nonp...
Elevance Health, Inc. (ELV) Q4 2025 Earnings Call Transcript
Elevance Health, Inc. (ELV) Q4 2025 Earnings Call Transcript
Elevance Health Q4 Earnings Review: No Sign Of An End To The Pain
Elevance Health, Inc. faces persistent margin and volume pressures, with Q4 operating revenue down 55% YoY and weak 2026 guidance. ELV's benefit expense ratio remains elevated at 90%, with medical inf...
US Health Insurer Elevance Health Issues Soft Outlook, Lower Premium Forecast For 2026
Elevance Health Inc. (NYSE: ELV) shares fell after the health insurer reported mixed fourth-quarter 2025 earnings and bleak fiscal 2026 guidance. The stock has recovered most of its loss from the prem...
Elevance Health Stock Dives Again. Why Earnings Are Adding to Medicare Pain.
Elevance Health stock was set to fall for second consecutive day Wednesday.
Elevance Health Reports $547 Million Profit Despite Rising Costs
Elevance Health Wednesday reported fourth quarter net income of $547 million as healthcare cost issues continued to drag earnings of the health insurance giant.
Elevance forecasts 2026 profit below estimates on elevated medical costs
Elevance Health forecast 2026 profit below Wall Street expectations on Wednesday, as the health insurer expects higher medical costs to persist into the year.
Elevance Health Reports Fourth Quarter and Full Year 2025 Results; Sets Full Year 2026 Outlook
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2025 results. "Elevance Health delivered fourth quarter results in line with our outlook, reflect...
Major health insurance stocks sank Tuesday, after Medicare said it was holding payments steady next year
Big health insurers lose nearly $90 billion in market capitalization after Medicare proposed a relatively flat rate increase for next year.
Health Insurer Stocks Flatline on Medicare Rates, UNH Example Trade
Marley Kayden covers the health insurance industry after the Trump administration kept Medicare rates relatively flat, as opposed to the 5%-6% they expected. She also looks at UnitedHealth (UNH), whic...
Trump Just Shocked Medicare Stocks — Will Seth Klarman Seize This Moment?
The Medicare Advantage trade just got repriced—by Washington. Donald Trump‘s administration proposed 0.09% rate hike for Medicare Advantage plans in 2027, a fraction of Wall Street's 4%–6% expectation...
Health insurers tumble after Trump administration proposes keeping Medicare Advantage rates flat next year
Shares of several big-name health care companies plunged after the Trump administration proposed nearly flat rates for Medicare Advantage insurers. In extended trading, Humana, CVS Health and UnitedHe...
Trump Administration proposes keeping steady Medicare rates paid to insurers, WSJ reports
The Trump Administration is proposing to keep Medicare payments to insurers roughly steady next year, the Wall Street Journal reported on Monday, noting the plan includes an average rate increase of j...
Health insurance executives pressed on affordability in Congress
Top executives from five of the nation's largest health insurers began testifying on Thursday to lawmakers in both the U.S. House of Representatives and Senate about the rising costs of Americans' hea...
Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2025 Results on January 28, 2026
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release fourth quarter and full year 2025 financial results on January 28, 2026, at 6:00 a.m. Eastern Standard Time (“EST”). Management ...
Elevance Health Reflects On The Changed Role of Health Plans
INDIANAPOLIS--(BUSINESS WIRE)--As 2025 draws to a close, Elevance Health highlights how today's health plans are evolving to better support their members in a broader range of situations that affect h...
AM Best Takes Various Credit Rating Actions on Elevance Health, Inc. and Most of Its Subsidiaries
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of “a+” (Excellent) of t...
Elevance Health Board Welcomes Amy Schulman as New Director, Reflecting Ongoing Commitment to Governance Excellence
INDIANAPOLIS--(BUSINESS WIRE)--The board of directors of Elevance Health (NYSE: ELV) today announced the appointment of Amy Schulman, a recognized healthcare executive, investor, and governance leader...
Anthem Blue Cross and Blue Shield Donates Over $60,000 to Support Holiday Food Distributions Across New York
NEW YORK--(BUSINESS WIRE)--Anthem Blue Cross and Blue Shield of New York today announced a donation of more than $60,000 to help fund more than 32 food distribution events in partnership with The Camp...
Impax U.S. Sustainable Economy Fund Q3 2025 Contributors And Detractors
Intel (INTC) rallied strongly in September as the company announced a partnership with Nvidia on integrating Intel's x86 central processing units (CPUs) with Nvidia GPUs in AI server systems. Oracle (...
Elevance Health Expands Virtual Assistant to Help Members Navigate Healthcare with Confidence
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health announced today that it expanded access of its Virtual Assistant, a digital experience designed to help members easily access information, understand the...
Elevance Health: The Potential Turnaround The Market Isn't Pricing In
Elevance Health is rated a Buy with a $400 price target, reflecting 18% upside and potential market outperformance. ELV trades at a significant discount to peers, with an 11x earnings multiple and str...